Skip to main content

Ranitidine bismuth citrate Pregnancy and Breastfeeding Warnings

Brand names: Tritec

Ranitidine bismuth citrate Pregnancy Warnings

Ranitidine bismuth citrate in combination with clarithromycin has been assigned to pregnancy category C by the FDA. Clarithromycin is assigned to pregnancy category C while ranitidine is assigned to pregnancy category B. Animal studies failed to reveal evidence of teratogenicity for ranitidine bismuth citrate. There are no controlled data in human pregnancy. Ranitidine bismuth citrate is only recommended for use during pregnancy when benefit outweighs risk.

See references

Ranitidine bismuth citrate Breastfeeding Warnings

There are no data on the excretion of ranitidine bismuth citrate into human milk.

See references

References for pregnancy information

  1. (2001) "Product Information. Tritec (ranitidine bismuth citrate)." Glaxo Wellcome

References for breastfeeding information

  1. (2001) "Product Information. Tritec (ranitidine bismuth citrate)." Glaxo Wellcome

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer